The Can-SOLVE CKD Network is pleased to announce that Dr. Claudio Rigatto has been appointed Chair of the network’s Research Operations Committee (ROC).
The purpose of the ROC is to assess key elements of Can-SOLVE CKD research projects and advise the project teams and steering committee accordingly. The ROC performs annual peer-reviews on all projects to evaluate and provide guidance for successful implementation of the research program. Membership includes patient and Indigenous partners, experts of research methodology and clinical research. The Committee provides guidance to the project teams on strengthening aspects of the projects, as required and may seek external advice when necessary.
Dr. Rigatto takes over the role of Research Operations Committee Chair from Dr. William Clark, who has held the position since January 2018. All of us across the Can-SOLVE CKD Network are grateful for Dr. Clark’s dedicated leadership and pleased that he will continue to be involved with the ROC in a senior advisory role.
Dr. Claudio Rigatto biography
Dr. Rigatto is a trained clinical epidemiologist. His research is focused on biomarkers as predictors of outcomes in both acute and chronic kidney disease. He is a lead investigator with the Winnipeg Cardiac Surgery Cohort, a prospective cohort study of renal outcomes after heart surgery, where his research focuses on intraoperative biomarkers of acute kidney injury. He is also one of the lead investigators for the CanPREDDICT Consortium, a prospective cohort of 2500 CKD patients followed by nephrologists across Canada exploring utility of newer markers of renal and vascular health in prediction of patient-important outcomes in CKD.
Dr. Rigatto is an Associate Professor at the University of Manitoba Faculty of Medicine and an attending Nephrologist at both St. Boniface and Seven Oaks General Hospitals. He received his medical training at the University of Manitoba, including a BSc. in Medicine and at Memorial University in Newfoundland where he received his MSc. in Medicine.